Showing results (21-30 of 25) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Frontiers in Neuroenergetics|April 2, 2013
Glucagon-like peptide-1 (GLP-1) raises blood-brain glucose transfer capacity and hexokinase activity in human brainMichael Gejl, Susanne Lerche, Lærke Egefjord, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 28, 2017
Capillary dysfunction is associated with symptom severity and neurodegeneration in Alzheimer's diseaseRune B Nielsen, Lærke Egefjord, Hugo Angleys, et al.Diabetologia|December 1, 2017
Effects of hypoglycaemia on working memory and regional cerebral blood flow in type 1 diabetes: a randomised, crossover trialMichael Gejl, Albert Gjedde, Birgitte Brock, et al.Frontiers in Aging Neuroscience|June 3, 2016
In Alzheimer's Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical TrialMichael Gejl, Albert Gjedde, Lærke Egefjord, et al.Plos One|January 9, 2014
Influence of GLP-1 on myocardial glucose metabolism in healthy men during normo- or hypoglycemiaMichael Gejl, Susanne Lerche, Annette Mengel, et al.Pageof 3